Download full report with analyst certification and important disclosures
Jan 28 2026, 07:00 GMT
Glanbia
Positive setup for 2026 – results due February 25th
DAVY VIEW
2025 was a game of two halves for Glanbia with downward earnings revisions being supplanted by upgrades as we exited the year. The business sits at the intersection of the protein mega-trend, which is translating into healthy top-line growth and strengthening momentum. Top-line growth across core activities is the key differentiator for Glanbia and the equity. See our recent report ‘Thoughts on recent Capital Markets Day – positive equity set-up’. FY25 results will be published on February 25th.
